Skip to main content

Miquel Vila Bover

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

Institutions of which they are part

Head of group
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Miquel Vila Bover

Institutions of which they are part

Head of group
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder.

In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN).

I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.

Projects

Inicio, progresión y extensión de la Enfermedad de Parkinson: rol de la neuromelanina, alfa-sinucleína y cuerpos de Levy

IP: Miquel Vila Bover
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 197230
Reference: PI10/00849
Duration: 01/01/2011 - 30/06/2014

Mecanismos de propagación y progresión de la enfermedad de Parkinson: rol de los cuerpos de Lewy

IP: Miquel Vila Bover
Collaborators: Jordi Bove Badell
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 35000
Reference: SAF2009-06575-E
Duration: 05/03/2010 - 04/03/2011

Ministerio de Ciencia

Grup de Recerca en Malalties Neurodegeneratives

IP: Miquel Vila Bover
Collaborators: Marta Martínez Vicente, Jordi Bove Badell, Thais Cuadros Arasa, Annabelle Parent
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 41600
Reference: 2009 SGR 664
Duration: 01/01/2010 - 30/04/2014

CIBER: Enfermedades neurodegenerativas

IP: Miquel Vila Bover
Collaborators: -
Funding agency: CIBERNED Enfermedades Neurodegenerativas
Funding: 387200
Reference: CB06/05/0017
Duration: 01/01/2007 - 31/12/2010

Related news

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients.

Related professionals

Alejandro  Henao  Paez

Alejandro Henao Paez

Physiology and Pathophysiology of the Digestive Tract
Read more
Amira Idrizovic

Amira Idrizovic

Research technician
Childhood Cancer and Blood Disorders
Read more
Cristina Gamez Cenzano

Cristina Gamez Cenzano

Senior researcher
Molecular Medical Imaging
Read more
Marc Molins Masdefiol

Marc Molins Masdefiol

Research technician
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.